WPC market in transition: Naturinform expands range of sustainable decking boards

Redwitz/Rodach
Consolidation has taken place on the European market for WPC products. Naturinform acquires parts of the production facilities of the Finnish company UPM, which had announced its intention to withdraw from the production of decking boards. The German WPC specialist will continue the production of the Piazza Pro and One decking boards previously marketed by UPM. The agreement will come into effect from October 2024.
Naturinform has announced that it will scrutinise the market opportunities resulting from this in the upcoming weeks and ensure the smooth supply of both products for customers. The company thus assumes a key role in the growing market segment of WPC decking boards.
With the acquisition of the UPM product lines, Naturinform is specifically strengthening its commitment to the co-ex-decking boards – these are WPC decking boards with an additional coating, which guarantees an exceptionally high level of robustness. At the same time, the company is driving its own previously announced investments in the production of a new co-ex product line, which is expected to be presented to the global public soon.
"We couldn't have imagined a better successor for our WPC products," explains Edward Robinson, Director UPM Profi. "Naturinform shares our values regarding quality, sustainability, and service. We are convinced that our products will continue to be in the best hands in the future and that the market will be reliably supplied."
Horst Walther, Director of Naturinform, sees the acquisition as a significant opportunity for growth: "The integration of UPM products significantly strengthens our position in the international market. Together with our own co-ex product range, we are convinced that we can continue to advance Naturinform successfully in the long term and open up new growth opportunities and markets."
Press/contact:
PR KOMMUNIKATION
Images


About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Main sponsor Schüco thrilled by sporting success - Schüco dresses Germany's tallest statue in a football jersey of Arminia Bielefeld19.5.2025 13:25:14 CEST | Press release
Bielefeld. Schüco, the specialist in windows, doors and façades, has kitted out the tallest statue in Germany in the football jersey of DSC Arminia Bielefeld. It is the long-time sponsor's way of giving a gift to all the fans upon the team reaching the final of the German Cup. In fact, Arminia Bielefeld has reached the final of the German Cup for the first time in the club's 120-year history – and has done so as a third division team!
Sony Music Entertainment: The Whole World is Dancing to "Chicken Banana" TikTok's New Obsession – And Already One of 2025's Biggest Viral Hits15.5.2025 12:00:00 CEST | Press release
Listen to the song here: https://www.youtube.com/watch?v=ig7EKb6BrQk
Prof Dr Klemens Joos back as CEO of the EUTOP Group14.5.2025 13:27:53 CEST | Press release
Brussels - Prof Dr Klemens Joos (56) has been back at the helm of the EUTOP Group as CEO since 13 May 2025. The background to this is an ambitious growth strategy up to 2035 for the EUTOP Group, which he founded in 1990 while studying business administration at the Ludwig Maximilian University (LMU) in Munich. Just one year after its foundation, the company had a representative office in Brussels. Today, the EUTOP Group has subsidiaries or representative offices in the capitals of all major European Union member states in addition to Brussels. Prof Dr Klemens Joos is also an honorary professor of ‘Business Administration - Political Stakeholder Management’ at the Technical University of Munich (TUM). Enquiries & Contact: Press department EUTOP Group +49 89 323700-0 eutop@eutop.eu
New record achieved: NTT DATA Business Solutions exceeds the previous year’s top figures in terms of both revenue and results12.5.2025 11:12:03 CEST | Press release
2024/2025 saw a double-digit revenue growth of 14.7 percent to 1.85 billion euros EBIT in three digits for the first time at 109.9 million euros (+35.9%) Close to a 50 percent increase in cloud subscriptions Proportion of international business tops 60 percent mark Optimistic outlook despite global uncertainties
Biomay Launches FDA-Grade CRISPR/Cas9 Nuclease for Off-the-Shelf Purchase9.5.2025 12:00:00 CEST | Press release
(Vienna, Austria) Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its off-the-shelf product portfolio for genome-editing applications. Clients purchasing Biomay´s Cas9 will benefit from the company´s unparalleled track record and expertise as a market-registered GMP-manufacturer of the nuclease. Biomay is the FDA-approved manufacturer of recombinant Cas9 as the essential component of CASGEVY®, the very first CRISPR genome editing product on the market. Biomay’s Cas9 (internal code “BMC9”) is based on the classical wild-type Cas9 nuclease from Streptococcus pyogenes. The Cas9 manufacturing process has been de novo developed, GMP-implemented and PPQ-validated by Biomay. GMP and RUO manufacturing is performed by fermentation with E. coli and by purification with chromatographic methods. By quality control with a comprehensive set of validated analytical assays, the consistent
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom